Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Organ transplantation is a medical marvel that saves lives and offers renewed hope to patients suffering from chronic ...

Anemia is common in patients who have both heart failure and chronic kidney disease, and there is an association between anemia and progression of both diseases. The main causes of anemia are ...

Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Op-Ed: Diet, exercise and stopping smoking will save many lives, especially in Brooklyn’s minority communities.

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Kidney disease occurs when the kidneys cant filter blood properly leading to various complications Read on to learn signs ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...

UnitedHealth CEO Andrew Witty’s recent public comments suggest he understands healthcare’s biggest problem. The question is: ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.